Posts

Showing posts with the label Diabetic Nephropathy Market

Global Market Study on Diabetic Nephropathy Asia to Witness Highest Growth by 2020

Image
A latest market research report added to the repository of Market Research Reports Search Engine (MRRSE) states that the diabetic nephropathy market will report a moderate CAGR at 5.6% from 2014 through 2020.  The report, published by Persistence Market Research, is titled ‘Global Market Study on Diabetic Nephropathy Market – Asia to Witness Highest Growth by 2020’. The study says that the diabetic nephropathy market approximated US$2,262.2 million in 2014, and will be worth US$ 3,145.9 million by the end of 2020. Diabetic nephropathy, a condition that increase the risk of mortality in diabetes patients, is being widely reported across the world due to the sheer increase in the number of obese people and diabetics. The disease affects the kidneys, ultimately rendering them ineffective. This has necessitated investments in formulating treatments for diabetic nephropathy, leading to a teeming therapy pipeline in major markets of the world. Browse Full Report with TOC :...

Top Rated Report: Global Market Study on Diabetic Nephropathy Asia to Witness Highest Growth by 2020

The increasing R&D investment in drug discovery and development and rising incidences of obesity are major factors adding growth to the market. Another growth factor is the heightened awareness about the diabetes and kidney-related disorders among people. Today, more people are being diagnosed with diabetes not just in developed regions but also in the emerging countries of the world. Browse Full Report With TOC: http://www.mrrse.com/reports/diabetic-nephropathy-market the past few years, a number of established players have made huge investments in the field of drug discovery and neuropathy R&D. Sanofi has a strong hold in the global diabetic nephropathy market in terms of drug discoveries and modes of treatments. Other market players such as the Eli Lilly and Company, Mitsubishi Tanabe Pharma, Pfizer, Inc., Novartis AG, Abbott Laboratories, Reata Pharmaceuticals, Inc., Merck & Co., Inc., AbbVie, Inc., and Bayer AG also hold smaller shares of market revenue in...